Streetbeat News

Earnings

ESPR

Esperion Therapeutics (NASDAQ:ESPR) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $-0.48. The company's past earnings performance shows a mix of beats and misses, with the share price reacting variably. Shares are currently trading at $2.61, down 57.04% over the last year. Investors will be keenly watching for not just the earnings outcome but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:02 pm

FULC

Fulcrum Therapeutics (NASDAQ:FULC) is scheduled to release its quarterly earnings report on 2024-02-27, with analysts expecting an EPS of $-0.43. The company's past earnings performance shows a mix of beats and misses, with the stock price reacting variably. Shares have risen 59.69% over the last 52 weeks, indicating positive long-term shareholder sentiment. Investors will be keenly watching for not just the earnings outcome but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:01 pm

LMAT

LeMaitre Vascular (NASDAQ:LMAT) is scheduled to release its quarterly earnings report on February 27, 2024, with an expected EPS of $0.36. Historical data shows mixed reactions to past earnings, with the last quarter beating estimates but resulting in a 2.45% share price drop. Over the last year, LMAT shares have increased by 23.52%, indicating a positive outlook among long-term investors.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:01 pm

INGN

Inogen (NASDAQ:INGN) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $-0.62. Investors are hopeful for a beat on this estimate and positive guidance for the next quarter. Inogen's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat followed by a 1.14% drop. Shares are currently trading at $9.19, down 40.97% over the last year, indicating a negative sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:01 pm

MNKD

MannKind (NASDAQ:MNKD) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $0.00. The company's past earnings performance shows a mix of beats and misses, with the share price reacting variably. Shares are currently trading at $3.55, down 33.62% over the last year. Investors will be keenly watching for not just the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:01 pm

QTRX

Quanterix (NASDAQ:QTRX) is scheduled to release its quarterly earnings report on February 27, 2024, with an estimated EPS of $-0.32. Historical data shows Quanterix has previously beaten EPS estimates, leading to positive stock price movements. Shares are currently trading at $24.87, reflecting a 127.09% increase over the last 52 weeks. Investors are optimistic but will focus on the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:01 pm

VTEX

Vtex (NYSE:VTEX) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $0.00. The company's past performance shows a pattern of beating EPS estimates, leading to positive stock price movements. Shares of Vtex have increased by 87.09% over the last 52 weeks, trading at $7.43 as of February 23. Investors are looking forward to not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:01 pm

DK

Delek US Holdings (NYSE:DK) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $-1.27. The company's past earnings performance shows mixed results with both beats and misses, and subsequent stock price reactions. Shares of Delek US Holdings have increased by 12.59% over the last 52 weeks, indicating a generally positive sentiment among long-term shareholders ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:01 pm

CBRL

Cracker Barrel Old (NASDAQ:CBRL) is scheduled to release its quarterly earnings report on 2024-02-27, with analysts expecting an EPS of $1.37. The company's past earnings performance shows mixed results, with a notable miss last quarter but a subsequent share price increase. Over the last year, CBRL shares have declined by 33.97%, reflecting investor concerns. Investors will be keenly watching for both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:01 pm

LNW

Light & Wonder (NASDAQ:LNW) is scheduled to release its quarterly earnings report on February 27, 2024, with an expected EPS of $0.67. The company's past performance shows a pattern of beating EPS estimates, leading to positive stock price movements. Shares are currently trading at $93.65, reflecting a 51.45% increase over the last 52 weeks. Investors are optimistic but will be closely watching the guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:00 pm